GK Gupta, PD Sarkar, R Manyal… - … Research Journal (BBRJ …, 2022 - journals.lww.com
Background: The evidence from various studies showed that patients with sickle cell disease (SCD) have altered components of hemostasis such as platelet function, procoagulant …
Background: Sickle cell disease (SCD) is a hereditary haemoglobinopathy characterized by deranged haematopoiesis, and intermittent occlusion of small blood vessels. Patients can …
Background: Sickle cell disease (SCD) is an autosomal recessive disorder that is characterised with chronic anaemia and painful crisis. SCD is associated with …
FI Buseri, ZA Jeremiah, WA Shokunbi - Hematology, 2006 - Taylor & Francis
The plasma levels of some blood coagulation parameters; prothrombin time,(PT), partial thromboplastin time with kaolin (PTTK), thrombin clotting time,(TCT), fibrinogen and factor X …
Background: There are documented established markers (indices) of disease severity in patients with sickle cell anemia (SCA) and they determine the course of the disease. This …
SO Onoja, BC Eluke, A Dangana, S Musa… - Medical Journal of …, 2020 - mjz.co.zm
Background: Sickle cell anaemia (SCA) is a genetic disorder that has been shown to facilitate certain forms of coagulopathy. However, there is a paucity of data that …
WH Saud, MK Hassan, SK Al-Salait - Journal of Applied …, 2017 - journals.lww.com
Background: Sickle cell disease (SCD) is considered to be a hypercoagulable state that contributes to the morbidity associated with the disease. Numerous mechanisms can …
CE Omoti - Annals of African Medicine, 2005 - ajol.info
Background: Sickle cell anaemia (SCA) is a major cause of morbidity and mortality in Africa where there is no readily available effective treatment. This study was designed to determine …
HD Meshay, MH Khamees, HA Wadaha - 2022 - iasj.net
Background: Characterization of hematological parameters in patients with sickle cell anemia can direct treatment goals toward strategies reducing morbidity and mortality rate …